Clinical utility of circulating tumor DNA profiling in detecting targetable fusions in non-small cell lung cancer
Fusion detection using ctDNA CGP showed high concordance with tissue tests and accuracy in predicting therapeutic responses in patients with non-small cell lung cancer. ctDNA CGP may provide an important diagnostic tool for fusion detection.
Authors
- Changhee Ha (ORCID: https://orcid.org/0000-0002-0750-5824)
- Hyun Ae Jung (ORCID: https://orcid.org/0000-0002-1583-4142)
- Jong‐Mu Sun (ORCID: https://orcid.org/0000-0001-9683-4111)
- Myung‐Ju Ahn (ORCID: https://orcid.org/0000-0002-5740-9654)
- Cheonghwa Lee (ORCID: https://orcid.org/0000-0001-8171-5005)
- Boram Lee (ORCID: https://orcid.org/0000-0002-7784-5971)
- Jong Won Kim (ORCID: https://orcid.org/0000-0002-9556-7143)
- Young-Gon Kim (ORCID: https://orcid.org/0000-0002-2025-613X)
- Yoon-La Choi
- Sehhoon Park
- Se-Hoon Lee
Institutions
- Samsung Medical Center (KR)
- Sungkyunkwan University (KR)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-10-24
- DOI
- https://doi.org/10.3389/fonc.2024.1463341
- Citations
- 2
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.57
Funders
- Korea Health Industry Development Institute